Navigating the New FDA Landscape: Opportunities and Challenges Ahead

Navigating the New FDA Landscape: Opportunities and Challenges Ahead

In the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape under the new administration, including new leadership and staff turnover, and their impact on drug development. They examine the FDA's cautious approach to AI, efforts to reduce animal testing, and the new National Priority Voucher Program aimed at expediting drug approvals. Tune in for an in-depth discussion that offers timely updates and expert perspectives on what might be in store for drug development stakeholders.

EPISODE OUTLINE

00:00:14 – Welcome to Conversations in Drug Development 00:01:16 – US Regulatory Environment Update 00:02:35 – Changes in FDA Leadership 00:03:19 – The Impact of Staffing Changes 00:05:54 – New Perspectives with Vinay Prasad 00:07:50 – Future of Cell and Gene Therapy Approvals 00:10:03 – Market Reactions and Funding Concerns 00:11:45 – Implications of FDA Cuts 00:12:29 – Marty McCary’s Vision for the FDA 00:14:46 – Navigating Conflicting Perspectives 00:15:45 – FDA Workforce and Operational Changes 00:17:21 – Review Process and Efficiency Challenges 00:20:43 – ELSA: AI in FDA Operations 00:22:54 – Reducing Animal Testing in Drug Development 00:25:05 – National Priority Voucher Programme Insights 00:31:21 – Future Outlook and Next Steps

Avsnitt(25)

The Most Essential Tips for Biotechs Seeking Investment

The Most Essential Tips for Biotechs Seeking Investment

Welcome to a special edition of Conversations in Drug Development, brought to you by the team at Boyds.  In this episode, our host Harriet Edwards hands over the mic to two of her colleagues to discus...

3 Juni 202423min

The Use of ATMPs in Oncology Clinical Trials

The Use of ATMPs in Oncology Clinical Trials

How can phase I studies with ATMPs address unmet needs in oncology and what are the challenges? In this episode of Conversations in Drug Development, Dr Katherine Bowen is joined by Pharmaceutical Phy...

21 Maj 202419min

How are GMO Regulations Impacting Clinical Development in Europe?

How are GMO Regulations Impacting Clinical Development in Europe?

In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modif...

25 Apr 202424min

US Drug Development: The Latest Regulatory Trends and Initiatives

US Drug Development: The Latest Regulatory Trends and Initiatives

In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA. This ...

19 Mars 202422min

The Regulatory Challenges of Rare Disease Drug Development

The Regulatory Challenges of Rare Disease Drug Development

To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease drug development. Dr Eric Hardter, Associate Direct...

28 Feb 202429min

The Drug Development Landscape: Trends and Predictions for 2024

The Drug Development Landscape: Trends and Predictions for 2024

We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss ...

22 Jan 202425min

Off-the-Shelf Cell Therapies: Breaking Barriers and Revolutionizing Patient Care

Off-the-Shelf Cell Therapies: Breaking Barriers and Revolutionizing Patient Care

In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to...

4 Dec 202320min

The Future of Drug Development: AI’s Role in Revolutionizing the Industry

The Future of Drug Development: AI’s Role in Revolutionizing the Industry

In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applicati...

8 Nov 202322min

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-ufo-bortom-rimligt-tvivel-2
rss-vetenskapsradion-2
medicinvetarna
sexet
paranormalt-med-caroline-giertz
hacka-livet
rss-spraket
vetenskap-och-halsa
rss-tidslinjen-podcast
dumforklarat
halsorevolutionen
bildningspodden
vetenskapsradion